Principal Megan Chacon Highlights Gratitude-Worthy Patent Litigation Trends in 2024

Principal Megan Chacon shared her perspective in IAM’s feature on five key U.S. patent litigation trends to be grateful for this Thanksgiving. She reflected on the USPTO’s "Drug Patent and Exclusivity Study," which challenged misconceptions about pharmaceutical patents by examining methodologies for determining the scope of a drug's IP protections.

Excerpt: “USPTO’s analysis helps to course-correct perceptions about the role of patents, the quality of patents, and their duration in the life sciences. Patents at all stages of innovation can be important for many of the pioneer life science companies that I work with to protect their drug products through litigation.”

Read the full article: Five US Litigation Trends to Be Grateful for This Thanksgiving